The bionic pancreas (BP), an automated system that controls blood sugar levels, may be useful in managing cystic…
Articles by Joana Carvalho, PhD
Boehringer Ingelheim announced the enrollment of a first patient in its Phase 2 BALANCE-CF 1 trial assessing the safety…
Scientists have discovered a new way to treat cystic fibrosis (CF) that involves delivering artificial proteins to patients’ lung…
Kristen Mudrack, PhD, a chemistry professor at Milligan College in Tennessee, has launched a research initiative to encourage…
The Cystic Fibrosis Foundation (CFF) is giving Eloxx Pharmaceuticals up to $1.61 million to support its planned Phase 2…
The lung clearance index (LCI) is more sensitive to changes in lung function in patients with mild cystic…
The clinical effectiveness and cost-benefit of several cystic fibrosis (CF) therapies will be the focus of a final evidence…
A defect in cellular metabolism is the root cause for the high incidence of lung infections caused by the bacteria…
The Scottish Medicines Consortium (SMC) is recommending against bringing two of Vertex Pharmaceuticals’ approved cystic fibrosis (CF) treatments —…
Italfarmaco SpAÂ entered an agreement with Neupharma to develop and commercialize an inhaled formulation of teicoplanin, one of…